Rexin-G

N/A

Report date: 2024/10/25 17:41:04

Base Information

Drug NameRexin-G
Drug Alias NameDeltaRex-GTargeted nanomedicineRetroviral Expression Vectors Bearing Inhibitory GenesTumour-targeted gene therapy vector-Epeius
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Retroviral vector
Mechanisms of ActionGene transferenceCyclin-G1 inhibitors
TargetsCyclin-G1
Therapy Area/IndicationsPancreatic NeoplasmsColorectal NeoplasmsBreast Neoplasms +[5] 
Global Approved IndicationsPancreatic NeoplasmsColorectal NeoplasmsBreast Neoplasms +[5] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryPhilippines
Original Approved Date2007/01/01
Country/TerritoryUnited StatesPhilippines
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesEpeius Biotechnologies Corporation
China Registration ClassN/A

Develop Information

Active CompaniesEpeius Biotechnologies Corporation
Inactive CompaniesEpeius Biotechnologies
Active IndicationsPancreatic NeoplasmsColorectal NeoplasmsBreast Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeL01
Related LinksN/A